Back to Search
KRISTEN HEGE, MD
MD
Medical Oncology Physician
NPI: 1710925987Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G74793(CA)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
G74793(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
G74793(CA)
Research & Publications (15)
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).
PMID 19556425·Blood·2009
3-trial
Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
PMID 18801509·J Urol·2008
3-trial
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation.
PMID 18316569·Clin Cancer Res·2008
4-observational
A clinical development paradigm for cancer vaccines and related biologics.
PMID 17198079·J Immunother·2007
6-review
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
PMID 17606721·Clin Cancer Res·2007
3-trial
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
PMID 16740763·Clin Cancer Res·2006
3-trial
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer.
PMID 16410826·Cancer Gene Ther·2006
3-trial
Recovery of a flawed hyperspectral imager calibration using optical modeling.
PMID 19475061·Opt Express·2004
8-other
Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course.
PMID 14978695·Am J Hematol·2004
5-case
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.
PMID 14970281·J Natl Cancer Inst·2004
3-trial
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.
PMID 12478069·AIDS·2003
8-other
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
PMID 12027564·Mol Ther·2002
3-trial
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
PMID 10910888·Blood·2000
3-trial
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
PMID 10887107·Blood·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2421
Quick Facts
- NPI
- 1710925987
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile